181 related articles for article (PubMed ID: 38540271)
1. miR-331-5p Affects Motility of Thyroid Cancer Cell Lines and Regulates BID Expression.
Orlandella FM; Imperlini E; Pane K; Luciano N; Braile M; De Stefano AE; Iervolino PLC; Ruocco A; Orrù S; Franzese M; Salvatore G
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540271
[TBL] [Abstract][Full Text] [Related]
2. CircRTN1 acts as a miR-431-5p sponge to promote thyroid cancer progression by upregulating TGFA.
Gao Y; Wang Y; Xu L; Xie X; Zhu L; Wang F
Hormones (Athens); 2022 Dec; 21(4):611-623. PubMed ID: 35804263
[TBL] [Abstract][Full Text] [Related]
3. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
4. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
Hou S; Lin Q; Guan F; Lin C
J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
[TBL] [Abstract][Full Text] [Related]
5. CircRNA ZNF609 promotes the growth and metastasis of thyroid cancer
Shi P; Liu Y; Yang D; Wu Y; Zhang L; Jing S; Shi H; Geng C
Bioengineered; 2022 Feb; 13(2):4372-4384. PubMed ID: 35135416
[TBL] [Abstract][Full Text] [Related]
6. The miR-199a-5p/PD-L1 axis regulates cell proliferation, migration and invasion in follicular thyroid carcinoma.
Lin J; Qiu Y; Zheng X; Dai Y; Xu T
BMC Cancer; 2022 Jul; 22(1):756. PubMed ID: 35818041
[TBL] [Abstract][Full Text] [Related]
7. LINC01311 exerts an inhibitory effect in thyroid cancer progression by targeting the miR-146b-5p/IMPA2 axis.
Liu M; Zhang L; Hu J; Yan C; Zhang Y; Yan Z
Transl Oncol; 2023 Jan; 27():101588. PubMed ID: 36423383
[TBL] [Abstract][Full Text] [Related]
8. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
[TBL] [Abstract][Full Text] [Related]
9. MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD.
Yang F; Sun Z; Wang D; Du T
BMC Cancer; 2022 Mar; 22(1):308. PubMed ID: 35317779
[TBL] [Abstract][Full Text] [Related]
10. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
[TBL] [Abstract][Full Text] [Related]
11. hsa-miR-195-5p inhibits cell proliferation of human thyroid carcinoma cells via modulation of p21/cyclin D1 axis.
Liu D; Li P; Wang X; Wang W
Transl Cancer Res; 2020 Sep; 9(9):5190-5199. PubMed ID: 35117886
[TBL] [Abstract][Full Text] [Related]
12. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis.
Yi D; Zhang D; He J
Cell Cycle; 2021 Dec; 20(24):2619-2637. PubMed ID: 34781815
[TBL] [Abstract][Full Text] [Related]
14. Clinical roles of miR-136-5p and its target metadherin in thyroid carcinoma.
Gao RZ; Que Q; Lin P; Pang YY; Wu HY; Li XJ; Chen G; He Y; Yang H
Am J Transl Res; 2019; 11(11):6754-6774. PubMed ID: 31814886
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer.
Dai SG; Guo LL; Xia X; Pan Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):486-495. PubMed ID: 30720155
[TBL] [Abstract][Full Text] [Related]
16. LncRNA ARAP1-AS1 targets miR-516b-5p/PDE5A axis to facilitate the progression of thyroid cancer.
Du Q; Huang L; Guo W
Anticancer Drugs; 2023 Jul; 34(6):735-746. PubMed ID: 36730555
[TBL] [Abstract][Full Text] [Related]
17. miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma.
Li J; Liu X; Li C; Wang W
J Cell Biochem; 2019 Aug; 120(8):12412-12421. PubMed ID: 30825222
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of hsa_circ_0001681 suppresses epithelial-mesenchymal transition in thyroid carcinoma via targeting to miR-942-5p/TWIST1 signaling pathway.
Wang T; Huang Y
J Bioenerg Biomembr; 2021 Oct; 53(5):609-620. PubMed ID: 34164767
[TBL] [Abstract][Full Text] [Related]
19. circCCDC66 promotes thyroid cancer cell proliferation, migratory and invasive abilities and glycolysis through the miR-211-5p/PDK4 axis.
Ren H; Song Z; Chao C; Mao W
Oncol Lett; 2021 May; 21(5):416. PubMed ID: 33841577
[TBL] [Abstract][Full Text] [Related]
20. miR-93-5p enhance lacrimal gland adenoid cystic carcinoma cell tumorigenesis by targeting BRMS1L.
Hao J; Jin X; Shi Y; Zhang H
Cancer Cell Int; 2018; 18():72. PubMed ID: 29760585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
